Menu Search
Equities

Embecta Corp

EMBC:NSQ

Embecta Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.86
  • Today's Change-0.14 / -1.00%
  • Shares traded99.87k
  • 1 Year change-21.34%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 19:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Embecta Corp's net income fell -68.52% from 223.60m to 70.40m despite flat revenues.
Gross margin66.42%
Net profit margin6.23%
Operating margin14.87%
Return on assets5.53%
Return on equity--
Return on investment7.91%
More ▼

Balance sheet in USDView more

Embecta Corp appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, although this company's debt load outweighs its assets, its Interest Coverage ratio, at 2.959810000000000, shows that it is comfortably able to pay interest expenses out of operating profits.
Current ratio2.11
Quick ratio1.61
Total debt/total equity--
Total debt/total capital1.88
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -68.68%.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)50.79%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		49.82
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.